November 7, 2022
mayank
SBI Healthcare Opportunities Fund
NAV Growth: Rs 253.9168
NAV IDCW: Rs 176.4142
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund Manager:
1) Tanmaya Desai
Education: Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Experience: Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 500 |
| Min. Withdrawal (Rs) | 500 |
| Min. No of Cheques | 12 |
| Min. Balance (Rs) | 1,000 |
| Lock-in Period | NA |
| Exit Load | 0.5% for redemption within 15 days |
Basic Details
| Fund House | SBI Mutual Fund |
| Launch Date | 01-Jan-13 |
| Return Since Launch | 15.74% |
| Benchmark | S&P BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 1,681 Cr |
| (As on 30-Sep-2022) | |
| Expense Ratio | 1.06% |
| (As on 30-Sep-2022) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 25.00% |
SBI Healthcare Opportunities Fund Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| SBI Helthcr Opp Dir | -2.58 | -0.15 | 3.46 | 7.84 | 7.91 | 3.04 | 26.26 | 13.14 | 7.18 | — |
| S&P BSE Healthcare TRI* | -6.15 | 0.06 | 3.83 | 7.36 | 1.63 | -2.3 | 23.2 | 11.68 | 5.14 | — |
| Equity: Sectoral-Pharma* | -4.96 | -0.69 | 2.36 | 4.75 | 5.45 | -1.33 | 25.69 | 14.96 | 8.43 | — |
| Rank within category* | 2 | 1 | 2 | 1 | 1 | 1 | 4 | 4 | 3 | — |
| Number of funds in category* | 11 | 11 | 11 | 11 | 11 | 10 | 9 | 4 | 3 | 0 |
SBI Healthcare Opportunities Fund Peer Comparison
| Fund name | Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) |
| SBI Helthcr Opp Dir | Unrated | 3.04 | 26.26 | 13.14 | 1.06 | 1,681 | 15.74 | 0.50 (15) | 9yrs 10mo | 25.00 |
| Nippon Ind Pharma Dir | Unrated | -1.63 | 26.21 | 17.06 | 1.04 | 4,656 | 16.67 | 1.00 (30) | 9yrs 10mo | 25.00 |
| ICICI Pru Pharma Hlthcr & Diagn Dir | Unrated | -1.41 | 26.65 | — | 1.21 | 2,537 | 18.73 | 1.00 (15) | 4yrs 3mo | 50.00 |
| Mirae Asset Helthcr Dir | Unrated | -1.21 | 29.84 | — | 0.56 | 1,728 | 22.21 | 1.00 (365) | 4yrs 4mo | 22.00 |
| DSP Helthcr Dir | Unrated | -0.42 | 29.97 | — | 0.81 | 1,177 | 24.58 | 1.00 (364) | 3yrs 11mo | 7.00 |
Portfolio Analysis
| No. of Stocks | 19 |
| Top 10 Stocks | 74.68% |
| Top 5 Stocks | 50.96% |
| Top 3 Sectors | 98.06% |
| Portfolio P/B Ratio | 5.23 |
| Portfolio P/E Ratio | 44.26 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 45,196 | 57,817 |
| Giant (%) | 16.19 | 19.95 |
| Large (%) | 36.13 | 36.55 |
| Mid (%) | 36.82 | 36.15 |
| Small (%) | 10.87 | 7.74 |
| Tiny (%) | — | 0.54 |
Chanakya’s Mutual Fund Guidance For SBI Healthcare Opportunities Fund
Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Apply Online: https://www.sbimf.com/en-us/quick-invest?action=panverification&SubBrokerCode=&EUIN=E455804&arn_code=ARN-245610&subbrokerARN=&utm_source=EasyLink
Stock Research Reports:
https://www.analysislibrary.com/
NFO Guidance:
https://sahifund.com/category/nfos/
Chanakya’s Mutual Fund Guidance on YouTube
https://www.youtube.com/c/ChanakyaNiPothi
Join Chanakya’s Telegram Channel @
https://t.me/chanakyanipothi